Paul J Sekhri's Net Worth
$11.2 Million
Who is Paul J Sekhri?
Paul J Sekhri has an estimated net worth of $11.2 Million. This is based on reported shares across multiple companies, which include VEEVA SYSTEMS INC, Enumeral Biomedical Holdings, Inc., ARYx Therapeutics, Inc., Biodel Inc, Nivalis Therapeutics, Inc., Longboard Pharmaceuticals, Inc., BiomX Inc., vTv Therapeutics Inc., Axcella Health Inc., and ARIAD PHARMACEUTICALS INC.
SEC CIK
Paul J Sekhri's CIK is 0001264519
Past Insider Trading and Trends
2021 was Paul J Sekhri's most active year for acquiring shares with 9 total transactions. Paul J Sekhri's most active month to acquire stocks was the month of May. 2018 was Paul J Sekhri's most active year for disposing of shares, totalling 15 transactions. Paul J Sekhri's most active month to dispose stocks was the month of November. 2024 saw Paul J Sekhri paying a total of $1,053,593.72 for 113,936 shares, this is the most they've acquired in one year. In 2022 Paul J Sekhri cashed out on 12,706 shares for a total of $2,354,254.10, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
VEEVA SYSTEMS INC (VEEV) Snapshot price: $214.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.14% | 329 |
—
|
—
| 15.68K |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
| +1.93% | 290 |
—
|
—
| 15.35K |
Jun 1
| |||
Form 4
| +1.96% | 290 |
—
|
—
| 15.06K |
Mar 1
| |||
Form 4
| +2.00% | 290 |
—
|
—
| 14.77K |
Dec 1
| |||
Form 4
| -14.72% | -2.50K |
$224.85 | -$562,125.00 | 14.48K |
Sep 11
| |||
Form 4
| +1.74% | 290 |
—
|
—
| 16.98K |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
| +1.91% | 313 |
—
|
—
| 16.69K |
Jun 1
| |||
Form 4
| -13.96% | -2.66K |
$181.93 | -$483,557.96 | 16.38K |
Scheduled
|
Mar 3
| ||
Form 4
| +1.67% | 313 |
—
|
—
| 19.04K |
Mar 1
| |||
Form 4
| -3.61% | -702.00 |
—
|
—
| 18.73K |
Dec 16
| |||
Form 4
| +1.64% | 313 |
—
|
—
| 19.43K |
Dec 1
| |||
Form 4
| +1.66% | 313 |
—
|
—
| 19.11K |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| +1.02% | 189 |
—
|
—
| 18.8K |
Jun 1
| |||
Form 4
| -37.15% | -11.00K |
$214.02 | -$2,354,254.10 | 18.61K |
Mar 31
| |||
Form 4
| +0.64% | 189 |
—
|
—
| 29.61K |
Mar 1
| |||
Form 4
| +0.65% | 189 |
—
|
—
| 29.42K |
Dec 1
| |||
Form 4
| +0.65% | 189 |
—
|
—
| 29.23K |
Sep 1
| |||
Form 4
| +0.75% | 216 |
—
|
—
| 29.05K |
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
| +170.22% | 18.16K |
$163.88 | -$10,013.88 | 28.83K |
Jun 17
| |||
Form 4
| +2.08% | 217 |
—
|
—
| 10.67K |
Mar 25
| |||
Form 4
| +0.15% | 16 |
—
|
—
| 10.45K |
Dec 22 - Dec 25
| |||
Form 4
| +2.12% | 217 |
—
|
—
| 10.44K |
Sep 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
| +3.01% | 299 |
—
|
—
| 10.22K |
Jun 20
| |||
Form 4
| -3.64% | -375.00 |
—
|
—
| 9.92K |
Jun 4
| |||
Form 4
| -15.26% | -1.85K |
$145.50 | -$269,757.00 | 10.29K |
Mar 27
| |||
Form 4
| +2.52% | 299 |
—
|
—
| 12.15K |
Mar 20
| |||
Form 4
| +2.60% | 300 |
—
|
—
| 11.85K |
Dec 20
| |||
Form 4
| -28.55% | -4.62K |
$146.11 | -$674,286.57 | 11.55K |
Dec 6
| |||
Form 4
| -3.74% | -628.00 |
$151.00 | -$94,828.00 | 16.16K |
Oct 4
| |||
Form 4
| +1.81% | 299 |
—
|
—
| 16.79K |
Sep 20
| |||
Form 4
| -3.52% | -601.00 |
$169.38 | -$101,797.38 | 16.49K |
Scheduled
|
Jun 24
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +3.81% | 627 |
—
|
—
| 17.09K |
Jun 13
| |||
Form 4
| -3.52% | -600.00 |
$127.53 | -$76,518.00 | 16.47K |
Scheduled
|
Mar 22
| ||
Form 4
| +3.82% | 628 |
—
|
—
| 17.07K |
Mar 13
| |||
Form 4
| -3.53% | -601.00 |
$85.00 | -$51,085.00 | 16.44K |
Scheduled
|
Dec 26
| ||
Form 4
| -34.63% | -9.03K |
$86.68 | -$782,670.74 | 17.04K |
Scheduled
|
Dec 18
| ||
Form 4
| +2.46% | 627 |
—
|
—
| 26.07K |
Dec 13
| |||
Form 4
| +122.04% | 13.98K |
$98.09 | -$590,136.64 | 25.44K |
Scheduled
|
Dec 3
| ||
Form 4
| -4.98% | -601.00 |
$103.67 | -$62,305.67 | 11.46K |
Scheduled
|
Sep 24
| ||
Form 4
| +5.49% | 628 |
—
|
—
| 12.06K |
Sep 13
| |||
Form 4
| -8.83% | -1.11K |
$82.80 | -$91,659.60 | 11.43K |
Scheduled
|
Jun 25
| ||
Form 4
| +5.03% | 601 |
—
|
—
| 12.54K |
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
| -4.08% | -508.00 |
$75.46 | -$83,609.68 | 11.94K |
Scheduled
|
Mar 21 - Mar 23
| ||
Form 4
| -27.08% | -4.62K |
$65.00 | -$300,430.00 | 12.45K |
Scheduled
|
Feb 28
| ||
Form 4
| +3.65% | 601 |
—
|
—
| 17.07K |
Dec 21
| |||
Form 4
| +121.39% | 9.03K |
$53.83 | -$590,544.79 | 16.47K |
Scheduled
|
Dec 7
| ||
Form 4
| +8.79% | 601 |
—
|
—
| 7.44K |
Sep 21
| |||
Form 4
| +19.32% | 1.11K |
—
|
—
| 6.84K |
Jun 21 - Jun 22
| |||
Form 4
| +23.97% | 1.11K |
—
|
—
| 5.73K |
Mar 22
| |||
Form 4
| +31.49% | 1.11K |
—
|
—
| 4.62K |
Dec 22
| |||
Form 4
| +217.24% | 2.41K |
$37.73 | -$663,713.52 | 3.52K |
Scheduled
|
Oct 11
| ||
Form 4
|
∞
| 1.11K |
—
|
—
| 1.11K |
Sep 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Enumeral Biomedical Holdings, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 175K |
$0.13 | $21,875.00 | 175K |
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARYx Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Biodel Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nivalis Therapeutics, Inc. (ALPN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||